期刊文献+

内皮抑素与角膜新生血管

下载PDF
导出
作者 李鸿博 戴功
出处 《淮海医药》 CAS 2009年第2期F0003-F0004,共2页 Journal of Huaihai Medicine
  • 相关文献

参考文献10

  • 1Imanishi J, Kamiyama K, Iguchi I, et al. Importance in wound healing and maintenance of transparency of the cornea[J]. Prog Reina Eye Res 2000,19( 1 ) :113-129.
  • 2Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human comess[ J]. Invest Ophthalmol Vis Sci ,2004,41 (9) :2514-2522.
  • 3Amano S, Rohan R, Kuroki M, et al. Requirement for vascular endothelial growth factor in wound and inflammtion-relate corneal neovascularization[ J ]. Invest Ophthalmol Ves Sci, 1998,39 ( 1 ) : 18-22.
  • 4Lai CM, Spilsbury K, Brankov M, et al. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA[ J]. Exp Eye Res,2002,75(6) :625-634.
  • 5冯怡,崔立斌,刘传暄,马清钧.人内皮抑素在毕赤酵母中的表达、纯化与生物功能研究[J].生物工程学报,2001,17(3):278-282. 被引量:15
  • 6Kim YM,Jang JW, Lee OH, et al. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase [ J ]. Cancer Res, 2000,60 ( 19 ) : 5410-5413.
  • 7Dhanaba M, Ramchandran R, Water M J, et al. Ostatin induces endothelial cell apoptosis [ J ]. J Biol chem, 1999,274 ( 17 ) : 11721- 11726.
  • 8Kang HY,Shim D,Kang ss,et al. Protein kinase B inhibits edostation-induced apoptosis in HUVECsE[ J]. J Biochem Mol Biol,2006, 39( 1 ) :97-104.
  • 9Wickstrom SA. Alitalo K, Keski-Oja J, et al. Endostatin associates with integrin 51 and caveolin-1 ,and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells [ J ]. Cancer Res,2002,62 ( 19 ) :5580-5589.
  • 10Nyberg P, Heikkia P, Sorsa T, et al. Endostatin inhibits human tongue carcinoma cell invasion and intravastion and blocks the activation of matrix metalloprotease-2,-9, and-13 [J]. J Biol Chem, 2003,278(25) :22404-22411.

二级参考文献18

  • 1[1]Folkman J. How is blood vessel growth regulated in normal and neo plastic tissue? G. H. A. Clowes memorial award lecture. Cancer Res,1986,46:467~473
  • 2[2]Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1995,1: 27~31
  • 3[3]Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med, 1971,18(285): 1182~1186
  • 4[4]Kerbel R S. A cancer therapy resistant to resistance. Nature, 1997,390 (6658): 335~336
  • 5[5]Hanahan D. A flanking attack on cancer, Nat Medd, 1998,4(1): 13~14
  • 6[6]Timothy Browder, Bwtterfield CE, Kraling BM et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant eance. Cancer Res ,2000,60:1878~1886
  • 7[7]O' Reilly M S, Boehm T et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88(2) :277~285
  • 8[8]Sasaki T, Fkai N et al. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J, 1998,17 (15): 4249~4256
  • 9[9]Dhanabal M, Ramchandran R, Waterman M J, Endostatin induces endothelial cell apoptosis. J Biol Chem, 1999,274 (17): 11721~11726
  • 10[10]Dhanabal m, Volk r, Ramchandran R. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun,1999,258(2) :345~352

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部